SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

SunTrust Robinson Humphrey Initiates Coverage On Regeneron Pharmaceuticals with Hold Rating, Announces $360 Price Target

SunTrust Robinson Humphrey initiates coverage on Regeneron Pharmaceuticals (NASDAQ:REGN) with a Hold rating and a $360 price target.

Benzinga · -

SunTrust Robinson Humphrey initiates coverage on Regeneron Pharmaceuticals (NASDAQ:REGN) with a Hold rating and a $360 price target.